{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:05:00Z","timestamp":1781723100696,"version":"3.54.5"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Integrated Research Facility, Division of Clinical Research"},{"DOI":"10.13039\/100000993","name":"Battelle Memorial Institute","doi-asserted-by":"crossref","award":["HHSN272200700016I"],"award-info":[{"award-number":["HHSN272200700016I"]}],"id":[{"id":"10.13039\/100000993","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 AI114776"],"award-info":[{"award-number":["RO1 AI114776"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,22]]},"DOI":"10.1093\/infdis\/jiy304","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T19:06:16Z","timestamp":1527015976000},"page":"S672-S678","source":"Crossref","is-referenced-by-count":51,"title":["Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures"],"prefix":"10.1093","volume":"218","author":[{"given":"Julie","family":"Dyall","sequence":"first","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Evans","family":"DeWald","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7403-8819","authenticated-orcid":false,"given":"Rajarshi","family":"Guha","sequence":"additional","affiliation":[{"name":"Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit J","family":"Hart","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Postnikova","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Logue","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter M","family":"Vargas","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Gross","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Michelotti","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Deiuliis","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S","family":"Bennett","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Crozier","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Holbrook","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J","family":"Morris","sequence":"additional","affiliation":[{"name":"Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carleen","family":"Klumpp-Thomas","sequence":"additional","affiliation":[{"name":"Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"McKnight","sequence":"additional","affiliation":[{"name":"Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Mierzwa","sequence":"additional","affiliation":[{"name":"Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Shinn","sequence":"additional","affiliation":[{"name":"Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J","family":"Glass","sequence":"additional","affiliation":[{"name":"Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M","family":"Johansen","sequence":"additional","affiliation":[{"name":"Zalicus, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B","family":"Jahrling","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"},{"name":"Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E","family":"Hensley","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Gene G","family":"Olinger","sequence":"additional","affiliation":[{"name":"Integrated Research Facility, Division of Clinical Research, Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Thomas","sequence":"additional","affiliation":[{"name":"Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M","family":"White","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,25]]},"reference":[{"key":"key\n\t\t\t\t2018112203534940500_CIT0001","article-title":"Post-exposure treatments for Ebola and Marburg virus infections","author":"Cross","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0002","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40506-017-0130-z","article-title":"Discovering drugs for the treatment of Ebola virus","volume":"9","author":"Bixler","year":"2017","journal-title":"Curr Treat Options Infect Dis"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0003","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0004","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","article-title":"A randomized, controlled trial of ZMapp for Ebola virus Infection","volume":"375","author":"Davey","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0005","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cell.2017.04.037","article-title":"Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses","volume":"169","author":"Wec","year":"2017","journal-title":"Cell"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0006","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2017.04.038","article-title":"Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability","volume":"169","author":"Zhao","year":"2017","journal-title":"Cell"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0007","doi-asserted-by":"crossref","first-page":"290ra89","DOI":"10.1126\/scitranslmed.aaa5597","article-title":"A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity","volume":"7","author":"Johansen","year":"2015","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0008","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1038\/emi.2014.88","article-title":"Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs","volume":"3","author":"Kouznetsova","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0009","doi-asserted-by":"crossref","first-page":"e60579","DOI":"10.1371\/journal.pone.0060579","article-title":"A systematic screen of FDA-approved drugs for inhibitors of biological threat agents","volume":"8","author":"Madrid","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic drug combinations tend to improve therapeutically relevant selectivity","volume":"27","author":"Leh\u00e1r","year":"2009","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0011","doi-asserted-by":"crossref","first-page":"E206","DOI":"10.3390\/v8080206","article-title":"Clomiphene and its isomers block Ebola virus particle entry and iInfection with similar potency: potential therapeutic implications","volume":"8","author":"Nelson","year":"2016","journal-title":"Viruses"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0012","doi-asserted-by":"crossref","first-page":"e0166318","DOI":"10.1371\/journal.pone.0166318","article-title":"Evaluation of the activity of lamivudine and zidovudine against Ebola virus","volume":"11","author":"Cong","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0013","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","article-title":"What is synergy","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0014","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/msb.2011.71","article-title":"Systematic exploration of synergistic drug pairs","volume":"7","author":"Cokol","year":"2011","journal-title":"Mol Syst Biol"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco","year":"1995","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0016","volume-title":"MacSynergyTM II","author":"Prichard","year":"1992"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0017","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"A three-dimensional model to analyze drug-drug interactions","volume":"14","author":"Prichard","year":"1990","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0018","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1128\/JVI.01272-14","article-title":"A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity","volume":"88","author":"Watt","year":"2014","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0019","author":"World Health Organization"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0020","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/cid\/ciw571","article-title":"Clinical and virological characteristics of Ebola virus disease patients treated with favipiravir (T-705)-Sierra Leone, 2014","volume":"63","author":"Bai","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0021","doi-asserted-by":"crossref","first-page":"e0005389","DOI":"10.1371\/journal.pntd.0005389","article-title":"Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted","volume":"11","author":"Nguyen","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0022","doi-asserted-by":"crossref","first-page":"e1002535","DOI":"10.1371\/journal.pmed.1002535","article-title":"Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques","volume":"15","author":"Guedj","year":"2018","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0023","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/15563657708987968","article-title":"Toxicology of ipecac: a review","volume":"10","author":"Manno","year":"1977","journal-title":"Clin Toxicol"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0024","author":"World Health Organization"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0025","doi-asserted-by":"crossref","first-page":"x170693","DOI":"10.1107\/S2414314617006939","article-title":"Apilimod","volume":"2","author":"Morris","year":"2017","journal-title":"IUCRData"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0026","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.1258758","article-title":"Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment","volume":"347","author":"Sakurai","year":"2015","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0027","author":"World Health Organization"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0028","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504605","article-title":"Effect of artesunate-amodiaquine on mortality related to Ebola virus disease","volume":"374","author":"Gignoux","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0029","doi-asserted-by":"crossref","first-page":"e56265","DOI":"10.1371\/journal.pone.0056265","article-title":"Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection","volume":"8","author":"Shoemaker","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature18615","article-title":"Toremifene interacts with and destabilizes the Ebola virus glycoprotein","volume":"535","author":"Zhao","year":"2016","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0031","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/acs.jmedchem.7b01249","article-title":"Target identification and mode of action of four chemically divergent drugs against Ebolavirus infection","volume":"61","author":"Ren","year":"2018","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0032","doi-asserted-by":"crossref","first-page":"e0004364","DOI":"10.1371\/journal.pntd.0004364","article-title":"A rapid screening assay identifies monotherapy with interferon-\u00df and combination therapies with nucleoside analogs as effective inhibitors of Ebola virus","volume":"10","author":"McCarthy","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0033","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0034","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2016.11.017","article-title":"Synergistic drug combination effectively blocks Ebola virus infection","volume":"137","author":"Sun","year":"2017","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0035","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.4049\/jimmunol.1302411","article-title":"PIKfyve, a class III lipid kinase, is required for TLR-induced type I IFN production via modulation of ATF3","volume":"192","author":"Cai","year":"2014","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0036","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJMoa1511410","article-title":"Ebola RNA persistence in semen of Ebola virus disease survivors - final report","volume":"377","author":"Deen","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0037","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","article-title":"Persistence of Ebola virus in ocular fluid during convalescence","volume":"372","author":"Varkey","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112203534940500_CIT0038","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3201\/eid2106.150176","article-title":"Lack of protection against ebola virus from chloroquine in mice and hamsters","volume":"21","author":"Falzarano","year":"2015","journal-title":"Emerg Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/suppl_5\/S672\/26689555\/jiy304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T17:59:59Z","timestamp":1751651999000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/suppl_5\/S672\/5043462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":38,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2018,6,25]]},"published-print":{"date-parts":[[2018,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy304","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,15]]},"published":{"date-parts":[[2018,6,25]]}}}